金宇生物技术股份有限公司 2025 年第三季度报告 证券代码：600201 证券简称：生物股份 金宇生物技术股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 422,836,855.69 | 17.76 | 1,042,40 ...

证券代码：600201 证券简称：生物股份 公告编号：临 2025-058 金宇生物技术股份有限公司 第十二届董事会第四次会议决议公告 二〇二五年十月二十八日 特此公告。 金宇生物技术股份有限公司 与会董事一致认为，公司 2025 年第三季度报告真实地反映了公司 2025 年第 三季度的财务状况和经营成果。 董 事 会 表决结果：8 票同意、0 票反对、0 票弃权。 本议案已经公司第十二届董事会审计委员会 2025 年第二次会议审议通过。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 金宇生物技术股份有限公司（以下简称"公司"）第十二届董事会第四次会议 通知于 2025 年 10 月 13 日以电子邮件、书面形式发出，会议于 2025 年 10 月 27 日上午 11：00 在公司会议室以现场和通讯表决相结合的方式召开,应参加表决的 董事 8 名，实际参加表决的董事 8 名，公司高级管理人员列席了会议。会议的召 集、召开程序符合《公司法》及《公司章程》的规定。会议由董事长张翀宇先生 主持，会议审议通过了如下议案： 2、审议并 ...

生物股份公告，公司于2025年10月27日召开第十二届董事会第四次会议，审议通过了《关于拟回购注销 2023年员工持股计划部分股票的议案》。因5名离职持有人尚未解锁的权益份额，公司将回购注销12万 股股票，回购价格为6.23元/股。此次回购注销完成后，公司股本结构将有所变动，但不会对公司的经 营业绩、财务状况产生实质性重大影响。 ...

生物股份公告，第三季度营收为4.23亿元，同比增长17.76%；净利润为1.01亿元，同比增长116.40%。 前三季度营收为10.42亿元，同比增长7.38%；净利润为1.61亿元，同比下降4.85%。 ...

Group 1 - The Agricultural, Animal Husbandry, and Fishery ETF (159275) showed stable performance with a 1.0% increase in intraday price and a transaction volume of 5.0954 million yuan, bringing the fund's latest scale to 209 million yuan [1] - Among the constituent stocks, Zhongxing Junye reached the daily limit, while Xiaoming Co. and Shengnong Development saw significant gains of 4.34% and 3.99% respectively. Conversely, Chenguang Biotech experienced a notable decline of 3.19%, with Honghui Fruits and Vegetables and Shennong Seed Industry also showing weaker performance with drops of 1.04% and 0.88% respectively [1] - The Ministry of Agriculture and Rural Affairs held a meeting on October 21 to discuss increasing grain and oil crop yields, emphasizing the promotion of technology integration and high-performance agricultural machinery, particularly supporting the promotion of genetically modified technology to enhance grain yields, which may benefit related seed and planting companies [1] - The core breeding source rate for lean pork in China has surpassed 90%, indicating progress in self-sufficiency in the livestock breeding industry, with leading companies like Muyuan Foods continuing to drive innovation in breeding [1] - According to Citic Securities, the supply in the pig farming industry continues to increase, with rising demand for fat pigs driving up prices, although farming remains unprofitable, potentially accelerating capacity reduction [1] - In the poultry farming sector, frequent outbreaks of avian influenza overseas create uncertainty in the introduction of grandparent stock chickens, which is favorable for the white feather chicken industry chain prices [1] - The seed industry is focusing on the progress of biological breeding expansion, the promotion of genetically modified corn, and industry mergers and acquisitions [1] - The demand in the animal health industry is expected to bottom out, with new product launches providing growth momentum. The domestic pet market continues to grow rapidly, while exports are only slightly affected by tariff disruptions [1] Group 2 - The Agricultural, Animal Husbandry, and Fishery ETF (159275) and its linked funds (Link A: 013471, Link C: 013472) passively track the Agricultural, Animal Husbandry, and Fishery Index, with the top ten weighted stocks including Muyuan Foods, Wens Foodstuff Group, Haida Group, New Hope, Meihua Biological, Dabeinong, Shengnong Development, Biological Co., Beidahuang, and Longping High-Tech [2]

Core Viewpoint - The company, Jiangsu Sihuan Biological Co., Ltd., has released its third-quarter financial report for 2025, ensuring the accuracy and completeness of the information disclosed [1][2]. Financial Data - The third-quarter financial report has not been audited [8]. - The company does not require retrospective adjustments or restatements of previous accounting data [3]. - There are no non-recurring profit and loss items applicable for the reporting period [3]. Shareholder Information - The company has provided details regarding the total number of shareholders and the shareholding status of the top ten shareholders [4][5]. Strategic Cooperation - Jiangsu Chenwei Ecological Park Technology Co., Ltd. has signed a strategic cooperation agreement with Jiangyin Xinguangfa Trading Co., Ltd. to provide a stable supply of seedlings, with a total contract value of 26,098,107 yuan [5]. Governance and Compliance - The company is in the process of formulating and revising several governance systems to enhance operational standards, in accordance with relevant laws and regulations [9][11]. - The board of directors has approved the third-quarter report and various governance proposals, all receiving unanimous support [12][14].

Core Viewpoint - The announcement details the self-inspection report regarding the trading activities of insiders and incentive participants related to the 2025 A-share restricted stock incentive plan, confirming compliance with relevant regulations and the absence of insider trading activities [1][6][7]. Group 1: Incentive Plan Overview - The company convened meetings on September 26, 2025, to approve the draft of the 2025 A-share restricted stock incentive plan and related proposals [1]. - The incentive plan was disclosed on September 27, 2025, in accordance with the relevant laws and regulations [1][2]. Group 2: Self-Inspection Process - The self-inspection covered the trading activities of insiders and incentive participants from March 27, 2025, to September 26, 2025 [2]. - All insiders filled out the "Insider Information Registration Form," and the company confirmed trading activities with the China Securities Depository and Clearing Corporation [3]. Group 3: Trading Activities Findings - During the self-inspection period, five individuals were found to have traded company stocks, but these trades occurred before they were aware of the insider information related to the incentive plan [4]. - Other than the five individuals, no other insiders engaged in stock trading during the self-inspection period [5]. Group 4: Compliance and Conclusion - The company adhered to the information disclosure management regulations and internal confidentiality measures throughout the planning of the incentive plan [6]. - No evidence of insider trading or information leakage was found prior to the public disclosure of the incentive plan [7].

证券之星消息，10月24日动物保健板块较上一交易日上涨0.21%，生物股份领涨。当日上证指数报收于 3950.31，上涨0.71%。深证成指报收于13289.18，上涨2.02%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 600201 | 生物股份 | 10.77 | 2.87% | 31.19万 | | 3.33亿 | | 002868 | *ST绿康 | 29.09 | 0.66% | 1.06万 | | 3076.64万 | | 688098 | 申联生物 | 10.75 | 0.66% | 10.98万 | | 261T | | 300871 | 回盛生物 | 20.75 | 0.48% | 2.93万 | | 6075.83万 | | 920729 | 永顺生物 | 9.68 | 0.31% | 8412.62 | | 814.20万 | | 002688 | 金河生物 | 6.68 | 0.00% | 11.07万 | | 7393 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688185 证券简称：康希诺 公告编号：2025-031 康希诺生物股份公司 关于注销回购A股股份并减少注册资本 暨通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、通知债权人的原因 2025年10月23日，康希诺生物股份公司（以下简称"公司"）召开2025年第一次临时股东大会审议通过了 《关于回购注销A股股份并减少注册资本的议案》。根据《中华人民共和国公司法》（以下简称"《公 司法》"）《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号一回购股份》，以 及《康希诺生物股份公司章程》等相关法律、法规及规范性文件规定，对于回购股份用于员工持股或股 权激励的，应当在回购实施完成后三年内按照依法披露的用途进行转让，未按照披露用途转让的，应当 在三年期限届满前注销。 鉴于公司在三年期限届满前未将全部回购股份用于员工持股计划或股权激励，公司拟将回购专用证券账 户中对应的406,098股股票全部予以注销，并相应减少公司注册资本。 本次回购 ...

证券之星消息，10月23日动物保健板块较上一交易日下跌0.88%，生物股份领跌。当日上证指数报收于 3922.41，上涨0.22%。深证成指报收于13025.45，上涨0.22%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002141 | 后丰控股 | 4.03 | 2.03% | 32.37万 | 1.29亿 | | 002868 | *ST绿康 | 28.90 | 1.44% | 1.07万 | 3075.79万 | | 603566 | 普莱柯 | 14.11 | 0.71% | 2.80万 | 3923.90万 | | 600195 | 中牧股份 | 7.44 | 0.40% | 6.17万 | 4556.91万 | | 603718 | 海利生物 | 7.05 | 0.14% | 5.07万 | 3564.93万 | | 002688 | 金河生物 | 6.68 | 0.00% | 10.42万 | 6913.79万 | | 920275 | 驱动力 ...